Acute Liver Failure and Artificial Liver Support-Clinical
• CA-01 Acute Liver Failure and Artificial Liver Support-Clinical

Acute Liver Failure and Artificial Liver Support- Basic
• BA-01 Acute Liver Failure and Artificial Liver Support-Basic Science

Alcoholic Liver Disease-Clinical
• CAL-01 Alcoholic Liver Disease: Clinical and Therapeutic

Alcoholic Liver Disease-Basic
• BAL-01 Alcoholic Liver Disease: Experimental

Hepatitis B and D-Clinical
• CB-01 Diagnostics, Epidemiology, Prevention, Natural History
• CB-02 Therapeutics: New and Approved

Hepatitis B and D-Basic
• BB-01 Virology, Pathogenesis, and Immunology

Biliary and pancreatic Neoplasia other than Liver cancer-Clinical
• CBN-01 Diagnostics and Liver Imaging of biliary and pancreatic neoplasia 
• CBN-02 Prognosis : biliary and pancreatic neoplasia 
• CBN-03 Surgery and Loco-Regional Therapy for biliary and pancreatic neoplasia 
• CBN-04 Targetted and systemic therapies for biliary and pancreatic neoplasia

Biliary and pancreatic Neoplasia other than Liver cancer-Basic
• BBN-01 Experimental carcinogenesis of biliary and pancreatic neoplasia

Hepatitis C-Clinical
• CC-01 Diagnostics, Epidemiology, Natural History
• CC-02 Therapeutics: Preclinical and Early Clinical Development
• CC-03 Therapeutics: New Agents (not approved, phase 2-3)
• CC-04 Therapeutics: Approved Agents

Hepatitis C-Basic
• BC-01 Virology, Pathogenesis, and Immunology

Cholestatic and Autoimmune Liver Diseases-Clinical
• CCA-01 PBC/PSC and Other Cholestatic Disease: Clinical and Therapeutics
• CCA-02 Autoimmune Liver Disease: Clinical and Therapeutics

Cholestatic and Autoimmune Liver Diseases-Basic
• BCA-01 Transport, Bilirubin, Cholesterol, Lipids and Bile Salts,   Cholangiocyte Biology and   Experimental Cholestasis
• BCA-02 Autoimmune Liver Disease:Experimental

Drug Induced Liver Injury-Clinical
• CD-01 Predictors of Drug Toxicity and Therapy

Drug Induced Liver Injury-Basic
• BD-01    Pathogenesis and Mechanisms
• BD-02    Drug Metabolism, and Toxicity

Hepatitis A and E-Clinical
• CE-01 Hepatitis A and E- Clinical and Therapeutic

Hepatitis A and E-Basic
• BE-01 Hepatitis A and Experimental

Liver Fibrogenesis and Non-Parenchymal Cell Biology-Clinical
• BF-01 Imaging and Noninvasive Markers of Liver Fibrosis 
• BF-02 Clinical and Translational Fibrosis Research and Therapy

Liver Fibrogenesis and Non-Parenchymal Cell Biology-Basic
• BF-01 Basic Fibrosis Research and Stellate Cell Biology

Genetic and Metabolic Disease-Clinical
• CG-01 Hemochromatosis, Wilson Disease, ∝-1 Antitrypsin Deficiency-Clinical
CG-02 Other genetic and metabolic disorders-Clinical

Genetic and Metabolic Disease-Basic
• BG-01 Hemochromatosis, Wilson Disease, ∝-1 Antitrypsin Deficiency-Experimental
BG-02 Other genetic and metabolic disorders-Experimental

Inflammation and Immunology-Basic 
• BI-01 Animal Models
• BI-02 Innate Immunity
• BI-03 Adaptive Immunity
• BI-04 Mechanisms of Injury and others

Liver Cancer -Clinical 
• CLC-01 Diagnostics and Liver Imaging of hepatocellular carcinoma
• CLC-02 Prognosis : Hepatocellular Carcinoma
• CLC-03 Liver transplantation, Surgery and Loco-Regional Therapy for Hepatocellular Carcinoma
• CLC-04 Targetted and systemic therapies for Hepatocellular Carcinoma

Liver Cancer -Basic 
• BLC-01 Experimental Hepatocarcinogenesis

Liver Transplantation and Liver Surgery-Clinical
• CLTS-01 Donor and Allocation Issues; Living Donor and Split Liver Transplantation, 
• CLTS-02 Immunosuppression, Outcomes, Complications of liver transplantation
• CLTS-03 Viral Hepatitis   and liver transplantation 
• CLTS-04 Hepatobiliary Surgery

Liver Transplantation and Liver Surgery-Basic
• BLTS-01 Cellular Immunobiology, Preservation and Cell Transplantation, Experimental

Molecular and Cellular  Biology and Stem Cell Therapy -Basic
• BM-01 Cell Structure; Function; Signal Transduction, Nuclear Receptors
• BM-02 Gene Expression and Gene Therapy
• BM-03 Stem Cell Biology- Basic Sciences
• BM-04 Stem cell therapy: Clinical

Non-alcoholic Fatty liver Disease-Clinical
• CNA-01 NAFLD: Clinical and Therapeutic

Non-alcoholic Fatty liver Disease-Basic
• BNA-01 NAFLD: Experimental

Portal Hypertension and Other Complications of Cirrhosis-Clinical
• CP-01 Ascites, Renal Dysfunction and Hepatorenal Syndrome
• CP-02 Varices and Bleeding
• CP-03 Encephalopathy and Infections and Other Complications
• C-P04 Acute on Chronic Liver Failure

Portal Hypertension and Other Complications of Cirrhosis including ACLF-Basic
• BP-01 Experimental\

Pediatric Hepatology-Clinical
• CPD-01 Biliary Atresia and Cholestasis
• CPD-02 Viral and Autoimmune Hepatitis
• CPD-03 Metabolic and Genetic Diseases
• CPD-04 Pediatric Liver Transplantation

Pediatric Hepatology-Basic
• BPD-01 Pediatric Liver Disease – Basic Science

Public Health Services Research
• CPH-01 Health Care Delivery/Access/Quality
• CPH-02 Health Economics and Cost-Effectiveness and Economics of Care
• CPH-03 Other public health issues

Miscellaneous-Clinical
• CM-01 Miscellaneous issues-Clinical

Miscellaneous-Basic
• BM-01: Miscellaneous issues-Experimental